Navigation Links
Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
Date:2/5/2013

ROCKVILLE, Md., Feb. 5, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today that its Chief Executive Officer, Jeffrey Riley , will present at the 2013 BIO CEO & Investor Conference. The conference will be held February 11-12, 2013 at the Waldorf-Astoria Hotel in New York City. Mr. Riley is scheduled to present on Tuesday, February 12, 2013 at 11:00 a.m. (Eastern Time).

A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the web at http://www.veracast.com/webcasts/bio/ceoinvestor2013/06212103.cfm. After the presentation, a replay will be archived and accessible for 30 days at the same website.

Mr. Riley, as well as Synthetic Biologics' CFO, C. Evan Ballantyne , and its EVP, Research & Development, John Monahan , Ph.D., will be available to participate in one-on-one meetings with investors who are registered to attend the conference.

About Synthetic Biologics, Inc.

Synthetic Biologics is a biotechnology company focused on the development of product candidates for serious infections and diseases. Synthetic Biologics is developing a biologic for the prevention of C. difficile infection, and a series of monoclonal antibodies for the treatment of serious infectious diseases, including pertussis and Acinetobacter. The Company is also developing a synthetic DNA-based therapy for the treatment of pulmonary arterial hypertension. In addition, the Company is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS, and is designing a clinical development pathway for the treatment of amyotrophic lateral sclerosis. For more information, please visit Synthetic Biologics' website at www.syntheticbiologics.com.

To download Synthetic Biologics' investor relations mobile device app, which allows users access to the Company's SEC documents, press releases and events, please click on the following links to download the IRapp on your iPhone and iPad or your Android mobile device.

 

 


'/>"/>
SOURCE Synthetic Biologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. New synthetic biology technique boosts microbial production of diesel fuel
2. UC Santa Barbara researchers develop synthetic platelets
3. Synthetic diamond steps closer to next generation of high performance electrochemical applications
4. Synthetic Biology Scorecard finds federal agencies responding to bioethics report
5. Collagen-seeking synthetic protein could lead doctors to tumor locations
6. Synthetic biofilter wins through to the top Sweet 16 in Boston
7. Nottingham part of £20m investment for UK synthetic biology
8. Microchoreography: Researchers use synthetic molecule to guide cellular dance
9. Synthetic fuel could eliminate US need for crude oil
10. New report finds increase in media coverage of synthetic biology
11. Synthetic and biological nanoparticles combined to produce new metamaterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/22/2017)... NEW YORK , March 21, 2017 /PRNewswire/ ... Customer Marketing Cloud used by retailers such as ... in its platform — Product Recommendations and Replenishment. Using ... to give more personalized product and replenishment recommendations ... purchases, but also on predictions of customer intent ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... ... March 27, 2017 , ... ... produce small, heterogeneous samples with limited tumor content in a large background of ... resolved, such as the need for reliable detection of low abundance somatic mutations, ...
(Date:3/27/2017)... DUBLIN , March 27, 2017 ... access to a comprehensive library of reports on Valero ... the transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... is biofuel production to go green. Ethanol today, even though ...
(Date:3/27/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it is now offering a ... consumers who want to have their DarioHealth products reimbursed ... alliance agreements with partners across the U.S. who will ... approved, will supply and bill the customer,s insurance for ...
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets has ... Research - Global Strategic Business Report" report to their offering. ... This report ... in US$ Million. Annual estimates and forecasts are provided for the ... primary and secondary research. The report profiles 25 ...
Breaking Biology Technology: